Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

Middle area:

Olivier Charmeil

Olivier Charmeil

  • Member of the Executive Committee and the Senior Leadership Team
  • Executive Vice President, Vaccines
 

Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d’Etudes Politiques in Paris. From 1989 to 1994, he worked in the Mergers & Acquisitions department of Banque de l’Union européenne.

He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently, he held various posts within the Group, including Chief Financial Officer (Asia) for Sanofi-Synthélabo in 1999 and Attaché to the Chairman, Jean-François Dehecq, in 2000, before being appointed as Vice President, Development within the Sanofi-Synthélabo International Operations Directorate, where he was responsible for China and support functions. In 2003, Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synthélabo France, before taking the post of Senior Vice President, Business Management and Support within the Pharmaceutical Operations Directorate. In this role, he piloted the operational integration of Sanofi-Synthélabo and Aventis. He was appointed Vice President Pharma Operations Asia Pacific in February 2006 and subsequently also had responsibility for Operations Japan and since February 2009 Asia/Pacific & Japan Vaccines.

Since August 2014, he represents the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) at the Gavi Alliance Board for a three-year term.

He has been appointed to his present post on January 1, 2011.

 

Right area:

Stock Market

Your services

 

© Sanofi 2004-2016 - All rights reserved - Update: January 04, 2016

  • Site complies with W3C WCAG 2.0 (new window, in english)